A Phase I Study to Evaluate LSALT Peptide

Clinical trial NCT03772678 · COMPLETED

Trial details

NCT number: NCT03772678
Sponsor: Arch Biopartners Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

None - Study is to Determine Safety in Healthy Participants

Start date: 2019-06-27
Primary completion: 2020-03-31
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.